Show simple item record

dc.contributor.authorBirru, Eshetie Melese
dc.contributor.supervisorKevin Battyen_US
dc.contributor.supervisorBrioni Mooreen_US
dc.date.accessioned2025-08-05T01:27:30Z
dc.date.available2025-08-05T01:27:30Z
dc.date.issued2025en_US
dc.identifier.urihttp://hdl.handle.net/20.500.11937/98224
dc.description.abstract

This thesis investigates the clinical use of benzathine penicillin G (BPG) in rheumatic heart disease and syphilis management, focusing on delivery constraints, safety concerns, and pharmacokinetics. Through qualitative research, systematic review, and population pharmacokinetic modeling, it examines provider apprehensions, logistical challenges, adverse reactions, and maternal pharmacokinetics. Despite BPG’s efficacy and favorable pharmacologic profile, findings underscore the need for optimized formulations, robust supply chains, and enhanced pharmacovigilance to ensure safer, more effective utilization, particularly in resource-limited settings.

en_US
dc.publisherCurtin Universityen_US
dc.titleClinical pharmacology studies of benzathine benzylpenicillin and benzylpenicillinen_US
dc.typeThesisen_US
dcterms.educationLevelPhDen_US
curtin.departmentCurtin Medical Schoolen_US
curtin.accessStatusOpen accessen_US
curtin.facultyHealth Sciencesen_US
curtin.contributor.orcidBirru, Eshetie Melese [0000-0002-7613-0384]en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record